Masaya Miyazaki

Executive Vice President

Masaya Miyazaki

Message

As a CRO, the role of our company is to deliver highly effective and safe pharmaceutical products and medical equipment to patients as soon as possible, so we need to provide expertise in the development of such products to our clients and to execute clinical trials rapidly and accurately. Another important responsibility is to ensure that ineffective or unsafe pharmaceutical products and medical equipment do not reach the market; or in other words, we need to avoid wasting R&D expenses and time. In doing all this, it is most important to safeguard the human rights of the research participants and to ensure the reliability of the trials as a third party. To be sure that all employees involved in development can execute their tasks with integrity, independence, and specialist know-how, we put a lot of effort into education and training, and also project team management. Currently, Linical is building a system that enables us to undertake development contracts as a complete package, both in Japan and overseas, and we are accumulating further experience in managing international projects from Japan in Japan-led international joint clinical trials. To ensure that all the work we do is carried out with the same attitude and to the same high standards in all the countries we operate in, we are building on our strong track record by applying an advanced Quality Management System (QMS), so that we can manage higher-quality, speedier clinical trials, even on a global scale.